Biotech Growth N V sold $12M of BDTX
owner at Black Diamond Therapeutics, Inc.. 5,784,292 shares at an average of $2.07, traded Mar 19, 2025, filed Mar 20, 2025.
Score components
- +12Role10% owner
- +25Trade size$12.0M at market
- +20Share of holdings soldSold 68% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-026305, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 19, 2025 | SOpen-market sale Common Stock | -1,000,000 | $2.07 | $2.1M | 7,517,839 | Mar 20, 2025 |
| Mar 19, 2025 | SOpen-market sale Common Stock | -300,000 | $1.94 | $583k | 7,217,839 | Mar 20, 2025 |
| Mar 19, 2025 | SOpen-market sale Common Stock | -1,000,000 | $2.31 | $2.3M | 6,217,839 | Mar 20, 2025 |
| Mar 19, 2025 | SOpen-market sale Common Stock | -2,000,000 | $2.00 | $4.0M | 4,217,839 | Mar 20, 2025 |
| Mar 19, 2025 | SOpen-market sale Common Stock | -400,000 | $2.09 | $837k | 3,817,839 | Mar 20, 2025 |
| Mar 19, 2025 | SOpen-market sale Common Stock | -584,292 | $1.95 | $1.1M | 3,233,547 | Mar 20, 2025 |
| Mar 19, 2025 | SOpen-market sale Common Stock | -500,000 | $2.12 | $1.1M | 2,733,547 | Mar 20, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.